Increased expression of IRF1, IRF2, IRF3, IRF4, IRF5, IRF7, IRF8, and IRF9 was associated with more advanced pathological grade and worse outcomes in glioma patients. The gene discussed is IRF8; the disease is central nervous system cancer.